Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation - Concepedia

Concepedia

Publication | Closed Access

Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation

77

Citations

22

References

2023

Year

Vijay Patil, Vanita Noronha, Nandini Menon, Ajay Singh, Sarbani Ghosh Laskar, Ashwini Budrukkar, Atanu Bhattacharjee, Monali Swain, Vijayalakshmi Mathrudev, Kavita Nawale,

Journal of Clinical Oncology

Abstract

The addition of docetaxel to radiation improved DFS and OS in cisplatin-ineligible patients with LAHNSCC.[Media: see text].

References

	Year	Citations

Page 1